Matches 1 - 50 out of 203 1 2 3 4 5 >


Match Document Document Title
US20130018109 Skin and hair treatments  
Linalool and other materials which are skin penetrating vasodilators or which can be made to have such properties are applied, either by themselves or in skin treatment compositions, to the skin...
US20110082218 TREATMENT AND MODULATION OF GENE EXPRESSION AND SKIN AGING  
Methods and compositions for treating modulating and/or ameliorating non-light-induced, particularly non-UV-induced, skin aging in a human, for reducing the basal MMP-10 expression in unirradiated...
US20110151009 USE OF FREE RADICAL SCAVENGERS FOR PROTECTING AND TREATING SKIN AND HAIR DAMAGES CAUSED BY CHEMOTHERAPY  
The present invention relates to the use of one or more free radical scavengers as prophylactically or therapeutically effective substances and microparticles having an average particle size...
US20100305214 Use of a Monoterpene to Increase Tissue Repair  
The invention relates to the use of a monoterpene to increase biological tissue repair, i.e. tissue regeneration or healing, the cosmetic use of a monoterpene to increase biological tissue repair...
US20140010859 BARLEY PROTEIN MICROCAPSULES  
The invention is directed to microcapsules, pharmaceutical or nutraceutical compositions comprising same, and methods for preparing and using same for delivery of nanoparticle coated emulsions...
US20110009351 SCREENING ASSAY TO IDENTIFY CORRECTORS OF PROTEIN TRAFFICKING DEFECTS  
The present invention relates to a novel assay or screen for identifying compounds with potential therapeutic value for the treatment of protein trafficking diseases such as Cystic Fibrosis (CF)...
US20130183281 METHODS AND COMPOSITONS FOR CELL-PROLIFERATION-RELATED DISORDERS  
Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
US20150202304 ENCAPSULATION OF IMMISCIBLE PHASES IN SILK FIBROIN BIOMATERIALS  
Embodiments of various aspects described herein relates to compositions and methods for encapsulation and/or stabilization of oil, lipid, hydrophobic and/or lipophilic compounds in a silk-based...
US20140249234 Compositions and Methods for Restoring the Stratum Corneum and Treating Dermatological Diseases  
The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to restore the stratum granulosum and stratum corneum and treat a dermatological...
US20140271758 OVERCOATED POWDER PARTICLES  
Provided are compositions comprising a collection of overcoated particles wherein each of the overcoated particles comprises a first coating and a second coating. In one embodiment, the first...
US20120308621 BASE FORMULATION FOR COSMETIC PRODUCTS  
The present invention relates to a base formulation for cosmetic products, characterized in that it comprises, in percentage by weight of the formulation and according to the INCI nomenclature: a)...
US20140302169 Method of Treating Ocular Disorders  
A method wherein subjects having or at risk for having hyperopia, presbyopia or astigmatism are administered a composition having an effective amount of ocular antioxidants, including specifically...
US20120070422 Method of Treating Ocular Disorders  
A method wherein subjects having or at risk for having hyperopia, presbyopia or astigmatism are administered a composition having an effective amount of ocular antioxidants, including specifically...
US20110135764 PEST CONTROL USING NATURAL PEST CONTROL AGENT BLENDS  
Embodiments of the invention relate to a composition for controlling a target pest, wherein the composition includes at least two active ingredients selected from the group consisting of thymyl...
US20140212507 METHOD FOR DETERMINING A THERAPEUTIC APPROACH FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)  
Disclosed is a method for determining a supplement regime for a subject diagnosed with age-related macular degeneration (AMD). The method involves determining the subject's risk of developing...
US20140187510 MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY  
The present invention is directed toward a method of treating a subject for a condition mediated by aberrant Wnt/β-catenin signaling by selecting a subject with a condition mediated by aberrant...
US20120046242 MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY  
The present invention is directed toward a method of treating a subject for a condition mediated by aberrant Wnt/β-catenin signaling by selecting a subject with a condition mediated by aberrant...
US20140348764 Methods of Blocking Ultraviolet Radiation and Promoting Skin Growth Using Terpenes and Terpenoids  
The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to rejuvenate the skin and increase the protective layer against irradiation by...
US20110158921 Methods of blocking ultraviolet radiation and promoting skin growth using terpenes and terpenoids  
The present invention provides methods of treating humans and animals with terpenes and terpenoids in order to rejuvenate the skin and increase the protective layer against irradiation by...
US20120322892 ORAL MICROEMULSION OF ELEMENE  
An oral microemulsion of elemene is disclosed. The microemulsion is made of elemene, surfactant, cosurfactant and water or buffer solutions with pH 5˜8. Said surfactant is selected form tweens,...
US20060217438 Treatment for herpes simplex virus and other infectious diseases  
Topical formulations and methods use are described herein for relieving symptoms created by herpes simplex, mouth ulcers, and yeast infections. The formulations comprise effective amounts of...
US20120270954 METHODS FOR MAINTAINING EYE HEALTH AND AMELIORATING OPTHALMIC MALADIES IN CANINES  
The invention provides novel methods for maintaining eye health and ameliorating ophthalmic maladies in canines by administering to the canines an ophthalmic malady ameliorating amount of one or...
US20140086879 Muscodor Albus Strain Producing Volatile Organic Compounds and Methods of Use  
Disclosed herein is an isolated Muscodor albus strain producing volatile organic compounds such as aristolene, 3-octanone and/or acetic acid ester, as well as cultures of said strain and...
US20050214389 Beta-carotene enriched extract from water hyacinth eichhornia crassipes  
The present invention provides a convenient and economical process for extraction and separation of β-carotene from water hyacinth Eichhornia crassipes (Pontederiaceae) comprising collecting...
US20110206638 COMPOSITIONS AND METHODS FOR REDUCING THE MUTATION RATE OF VIRUSES  
The disclosure provides compositions and methods for reducing the mutation rate of a virus, such as an RNA virus or a DNA virus, in a cell infected with the virus by, in one aspect, contacting the...
US20150004238 EMULSIONS PROVIDING STABLE VITAMIN COMPOSITIONS AND METHODS OF FORMING COMPOSITIONS THEREOF  
Stable vitamin oil-in-water emulsions and methods of making those emulsions are described herein. The emulsions may be used to make beverage products that include fat-soluble vitamins. The...
US20150018430 HUMIDITY ACTIVATED FORMULATION FOR VOLATILE COMPOUNDS  
This invention is related to controlled release formulations of volatile antimicrobial compounds against pathogens affecting meats, plants, or plant parts or dairy products. Provided are delivery...
US20080255246 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease  
The subject application relates to methods of treatment of peripheral vascular disease (PVD) as well as ischemic osteonecrosis, peritoneal ischemia, chronic ocular disease, macular degeneration,...
US20140234398 Dissolution of Arterial Plaque  
Some embodiments of the present invention provide pharmaceutical formulations, for treating atherosclerosis in a mammal, including a bile acid and/or a terpene atherosclerotic plaque emulsifier....
US20080280996 Use of Carophyllenes in the Manufacture of Medicaments and Treatment of Bodily Conditions of Inflammation and Inflammatory Pain  
The invention concerns the use of caryophyllenes related to medicaments and to the treatment of bodily conditions of inflammation and inflammatory pain.
US20080038391 Stable and bioavailable compositions of isomers of carotenoids for skin and hair  
The present invention relates to a method of manufacturing a stable composition enriched in cis-lycopene (z-isomers) by prolonged heating in solvents of tomatoes, parts of tomatoes, derivative...
US20110319790 PHARMACEUTICAL COMPOSITION AND SYSTEM FOR PERMEABILIZING FETAL MEMBRANES  
Provided is a pharmaceutical composition for permeabilizing fetal membranes including an active ingredient having a log K in the range of 2 to 4, where K is the octanol/water partition...
US20140094425 METHODS FOR TRANSDIFFERENTIATION OF BODY TISSUES  
The invention relates to methods for transdifferentiation of body tissues which can be used to generate specific cell types needed for regenerating organs or body parts, following cellular...
US20050169999 Process for production of water-dispersable formulation containing carotenoids  
The invention relates to a method for the production of a water-dispersible formulation containing carotenoids. The β-carotene was dissolved in n-isobutyl acetate and the hot solvent phase was...
US20150250884 METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY  
One aspect of the invention relates to AI-helper compositions comprising an AI compound (e.g., melatonin, alpha-lipoic acid, vitamin E, vitamin D, glutathione, resveratrol, astaxanthin, beta...
US20150051298 METHODS FOR PRODUCING OPTIMAL STABLE NANOEMULSIONS AND FORMULATIONS OBTAINED THEREFROM  
A method for producing stable nanoemulsions having a desired droplet size and functional properties tailored for use in a specific application (which is referred to as substantially optimizing...
US20130281533 Pet Food Compositions and Methods for Weight Loss and Matinenance  
The present invention provides food compositions and methods for companion animals that are effective in preventing or treating obesity.
US20070082064 Nutritional or dietary supplement for the treatment of macular degeneration  
A nutritional or dietary supplement composition that promotes retinal health through the prevention and/or treatment of visual acuity loss by reducing the risk of developing age-related macular...
US20050112210 Eye nutritional supplement  
Nutritional supplements formulated to address eye health are described herein. The supplements include vitamins, minerals, and antioxidants such as vitamins A, C, E, zinc, lutein and zeaxanthin....
US20050032914 Lutein/zeaxanthin for glare protection  
The invention relates to the improvement of visual performance, particularly of visual performance in the darkness, by administration of a colorant that is capable of being incorporated into eye...
US20110207831 READY-TO-USE, STABLE EMULSION  
The present invention relates to a stable emulsion, ready for use, of fat-soluble vitamins or carotenoids, a process for the preparation thereof, and the use thereof as addition to animal feeds,...
US20110117194 PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKER  
The present invention provides a pharmaceutical formulation containing an angiotensin-II receptor blocker and a release-control material as a pharmacologically active ingredient and a...
US20120071550 Synergistic combinations of cartonoids and polyphenols  
The present invention provides a therapeutic composition comprising one or more polyphenols and one or more carotenoids selected from the group consisting of lutein, lycopene and beta-carotene....
US20050031557 Oral administration of beta-carotene, lycopene and lutein for human skin protection  
Methods of improving the sun protection factor of human skin and methods of inhibiting the aging of human skin via the oral administration of a composition comprising (a) β-carotene, (b) lutein...
US20110150968 DISSOLVABLE DIETARY SUPPLEMENT STRIP AND METHODS FOR USING THE SAME  
A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or...
US20130274324 COMPOSITIONS OF FAT-SOLUBLE ACTIVE INGREDIENTS CONTAINING PLANT PROTEIN-SOY POLYSACCHARIDE COMPLEXES  
The present invention relates to compositions comprising a) 0.1 to 70 weight-% based on the composition of one or more fat-soluble active ingredients; b) one or more plant protein(s) chosen from...
US20060127505 Anti-inflammatory formulations  
The invention features compositions and methods for reducing inflammation of ocular tissue by administering to an individual a mixture of ingredients containing carotenoid and a polyphenol compound.
US20050027003 Methods of therapeutic treatment using retinoids with reduced side effects  
Methods including systemically, preferably orally, administering retinoid components to a human or animal to provide the desired therapeutic effect and at least one fewer side effect or at least...
US20110196383 Atherosclerotic Plaque Dissolution Composition  
A method and chemical composition for modifying and dissolving atherosclerotic plaques formed in a patient's blood vessels is provided. A chemical composition comprising one or more of an organic...
US20060148907 Topical antinflammatory preparations of y-terpinene  
An anti-inflammatory agent comprising from 0.01-1.0% γ-terpinene in a pharmaceutically acceptable vehicle.

Matches 1 - 50 out of 203 1 2 3 4 5 >